2339 GMT - Ansell's bull at Macquarie continues to see value in the stock despite the share-price surge that met the protective-garment maker's stronger-than-expected first-half earnings. An analyst note from the investment bank tells clients that the Australia-listed company's upgraded full-year guidance implies 4% in annual organic Ebit growth. The bank's analyst is slightly more optimistic on this metric, and forecasts 5% organic Ebit growth. The stock jumped 8.1% on release of the first-half result, but Macquarie maintains its outperform rating. Its target price rises 26% to A$40.30. Shares are down 2.6% at A$36.79. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
February 10, 2025 18:39 ET (23:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.